#LymphoidWorld AgoraH Reunion hoy en Madrid! @sehhematologia.bsky.social #TopHematoRulers! #HematoSpain #HematoMola!

Piropos de verdad! Comentarios que alegran el día y dan sentido al #HematoWorld! Tratando de inspirar a los #MIR25 desde el ejemplo y los resultados! 5 de mayo! Empieza la selección de plazas! #EligeHematologia! @sehhematologia.bsky.social Si aún tienes dudas… mis DM están disponibles 24/7

New comment on @bloodjournal.bsky.social of our #ICOnic @albertomussetti.bsky.social & @annasureda.bsky.social about Prizloncabtagene autoleucel: New #CART for cell B #Lymphoma! Available here ⬇️⬇️⬇️⬇️⬇️⬇️⬇️⬇️⬇️⬇️ ashpublications.org/blood/articl...

🚨 NEW #ICOnic PUBLICATION 🚨 Congratulations @martape28.bsky.social et al. For this paper! Now available online ⬇️⬇️⬇️⬇️⬇️⬇️⬇️⬇️⬇️⬇️⬇️⬇️ www.nature.com/articles/s41...

What a great meeting #EBMT25 with a great and #ICOnic participation of Institut Català d’Oncología Until the next one! See you in Madrid #EBMT26

Non-ICANS neurological complications after CAR T-cell therapies: recommendations from the EBMT Practice Harmonisation and Guidelines Committee authors.elsevier.com/a/1ks1w5EIIg...

🚨 New Research Alert! 🚨 A machine learning tool is aiding patients with #myelofibrosis and doctors in making better #transplant decisions! Developed by The EBMT, it outperforms traditional methods. Read more in the press release: www.hematology.org/n...#myelofibrosis#transplant #Hematology #HemeOnc #HemeSky #MedSky

Patients with Hodgkin lymphoma refractory/intolerant to both BV & checkpoint inhibitors (an increasing reality in the modern era) have median OS 7.4 yrs. This is a new benchmark in novel trials for R/R cHL. Thank you for the opportunity to participate! #lymsm #medsky www.nature.com/articles/s41...

Post-transplant cyclophosphamide in matched donor transplantation, current state of the art 📌 www.sciencedirect.com/science/arti...

I feel like we could all use something fun to look forward to right about now!!! 🧪🧪🧪 Abstract submission and registration are open for the FASEB Hematologic Malignancies Conference. This is always the BEST meeting!!! Please RT! events.faseb.org/event/hemato...

🎄Merry Xmas🎄 #HematoRulers around the world! Patients, families and colleagues, my best wishes for all of you! I know some of you are not at your best moment right now, but all of us are rooting for you! We can do this! We won’t stop until We’ve beaten Blood Cancer! 💪🏼

If you joined @bsky.app during @ash-hematology.bsky.social #ASH24 here’s a starter pack for transplant, cell & gene therapy #bmtsm #CARTcells #generherapy go.bsky.app/7xxh8WW

#ASH24 plenary: ketogenic diet & CAR-T efficacy - ketogenic diet➡️cytokine release & CAR expansion in mouse xenograft via beta-hydroxybutyrate - in pts, BHB correlates w/ CAR expansion and giving BHB to 3 pts enhanced T-cell oxphos Fascinating! BHB + CAR-T trial is open. #tcellrx

The slide set is almost ready!! I am excited to present our data at #ASH24 💪🏼 Thank you @ash-hematology.bsky.social for the opportunity and @haemophage.bsky.social for the phenomenal mentorship 🙌🏼 See you all soon 😍 #MedSky

#ASH24 Energy matters! Ketogenic Diet Enhances CAR T Cell Antitumor Function Via β-Hydroxybutyrate #CARTCell #TCell #tcellrx #immunotherapy @PennMedicine ash.confex.com/ash/2024/web...

Four haikus, one post, A cascade of thought and art— ASH voices converge. Thanks @stephxie.bsky.social for the #ASH24 #ASHaiku!

17. #MajorPROsASH: Lactuamab CTCL PROs #lymsm - SS: decreased itch & improved Skindex-29 scores as early as week 5, sustained up to week 45 - MF: PRO improvements occurred later (weeks 29-37) Differing trajectories of (sustained!) PRO improvements in SS vs MF. #ASH24

16. #MajorPROsASH: STARGLO RCT PROs #lymsm #ASH24 - clinically better pain, lymphoma sx w/ glofi at C3 (both arms sig at C5) - median time to deterioration of fatigue worse with glofi (1.6 v 4 mos)➡️fatigue d/t glofi? - EOT: sustained improvements in pain & lymphoma sx both arms

🌟 ABX Pearl of the Day: ESBL cystitis 💡 Q: Can I use amoxicillin/clavulanate to treat ESBL E. coli cystitis if the micro reports it being susceptible? #IDsky #MedSky #PharmSky #SkyRX #AMSsky

Please join us in welcoming the incoming 2025 ASH President @b-avalos-md.bsky.social to our thriving Bluesky community! #HemeSky #Hematology #ASH24 🎉

20. #MajorPROsASH: CLL13 PROs #leusm - RV/GV: global QOL w/ sustained improvement - GIV: QOL did not improve during tx! - median time to improvement fatigue: ~5 mos in RV/GV/GIV arms - diarrhea worse with GIV vs all other arms Worse sx burden with GIV! Stick with GV. #ASH24

Applications for MSK's QSURE 2025 summer #internship program are now open! This program provides undergraduate students hands-on experience in quantitative science research. Applications are due by 5pm ET on 1/18. Apply ⬇️ www.mskcc.org/departments/...

If you haven’t seen it yet, the #ASH24 app allows us to search by disease. I see lots of #hemostasis and #thrombosis to choose from, as well as tons of other other cool science. #hemesky is bright!

📹 Make the most of the ASH Annual Meeting — here's what you need to know before you go! www.youtube.com/watch?v=QGDX... Learn about registration hours and locations, download the #ASH24 app, & preview the virtual platform and the new food guide! 😋🍔Check your email. #HemeSky #Hematology

< 2 wks to #ASH24, here is a📝 of 🔑abstracts from #CommunityOncologists perspective. - CART Sequencing - #EpcoreNHL1 - #inMIND - #EA4151 - #POLARIX - #CARTITUDE4 - #BMTCTN0702 - #KOMET007 - #LUNA3 #MedEd #mmsm #lymsm #leuksm #HemeSky @ash-hematology.bsky.social #OncSky

🌟 Attention trainees! ASH-a-Palooza is just one week away! There’s still time to register for this trainee-focused party full of beats, free bites, & burst of learning. Kicking off #ASH24 next Friday! Register: bit.ly/ASH-a-Palooza #ASHTrainee #HemeSky #Hematology #Fellow #MedSky #HemeOnc

#ASH24 of the day: Talquetamab Bridging before CAR-T -Talq bridging: 62% ORR (14% CR) -Post-CAR-T: 97.5% ORR (35% CR) -Safety: Mild toxicities during talq (no grade ≥3 CRS, 2.5% ICANS) -Post-CAR-T: less CRS (65%), ICANS (2% grade 3) Should be standard of care #mmsm @ash-hematology.bsky.social

Myeloma / Plasma Cell Dyscrasia ~ #ASH24Top10 (or so) #mmsm #mmMRD #ASH24 - @mtmdphd *DRAFT* Table Update: Dec 1, 2024 - cc @grpetersen1 - @bdermanmd @bhemato @End_myeloma @HadidiSamer @jmikhaelmd @ManniMD1 @MeeraMohanMD @MyelomaTeacher @RahulBanerjeeMD @rajshekharucms @szusmani @VincentRK

Thank you to Hanna Mikkola for previewing one of the most exciting sessions at #ASH24 in our latest #ASHinaFlash! Want to see it for yourself? there is still time to register for #ASH24, both in-person and virtually. #hematology #HemeSky #BloodSky www.youtube.com/watch?v=g_I1...

For #WorldAIDSDay sharing a paper (1996) from my postdoc in #HIV immunology - remembering a time with far less treatment options & paying tribute to the patients I consented to donate blood samples for the study - many passed away before the paper came out www.liebertpub.com/doi/10.1089/...

Join me and many others to Combat Hunger & Food Insecurity. I just donated to 2 local charities that support NYC and our patients nycommonpantry.org giving.mskcc.org/food #DiagnoseandTreats #HCWvsHunger www.feedingamerica.org/find-your-lo... Log Your Donation: hcwvshunger.org/how-to-donate/

Good morning! Thankful for all of you turkeys out there but especially those that want to help us feed others. #HCWvsHunger 2024 starts tonight at 6pm EST. You can help in many ways 🍎 post/repost 🍎 donate to any org fighting hunger & log donation at HCWvsHunger.org 🍎 invite everyone you know

@pkrugman.bsky.social on why it's time to leave the other platform for @bsky.app www.nytimes.com/2024/11/18/o...

Liso-cel + ibrutinib R/R CLL @wwierda #ASH24: - 56 pts, 37% TP53mut - ORR 86%, CR/CRi 45%, mDOR 41 mo - mPFS 31 mo, mOS NR, uMRD 86% - no G5 TEAEs, 2% afib, 4% G3+ CRS, 11% G3+ ICANS Would love to see TP53 & high-risk subgroups. #lymsm #leusm

8 days ago, ASH decided to join Bluesky. 🌤️ So far, we're enjoying fewer distractions & more meaningful connections. 💬 Engaging with our amazing #hematology and #hemeonc communities has never been easier. We created an #ASH24 feed for you & we have more feeds coming soon: bit.ly/ASH24feed #Hemesky

A great case showcasing how close collaboration between hematology and neurology is key to managing patients with #CART-related toxicities @hematorules.bsky.social

It’s out now! EBMT Clinical Case of the Month! Our very first work together Roser Velasco @velascoroser.bsky.social #ICOnic Team! 💪🏼 Check it out here ⬇️⬇️⬇️⬇️⬇️⬇️⬇️ www.ebmt.org/ebmt/news/cl...

Excellent work!!! Congratulations Claire Roddie www.nejm.org/doi/full/10....

🚨Last call: The deadline to apply for the Cancer Biology or Cancer Engineering #PhD programs at MSK's Gerstner Sloan Kettering graduate school is 12/1. Don't miss the opportunity to make the next groundbreaking discovery in cancer & biomedical sciences. Apply: www.sloankettering.edu/gerstner/adm...

#IMPRESCINDIBLE #VIDEO 🔴 Uno de los tratamientos más innovadores en la última década es la terapia #CAR-T, que está permitiendo rescatar a #pacientes que antes no tenían ningún tratamiento activo. x.com/sehh_es/stat... #HematoEnRed

Check out a preview of the session on #lymphoma with session co-chair, Dr. Koff! #ASHinaFlash brings you small doses of the latest #hematology breakthroughs at #ASH24! #HemeOnc #OncSky #HemeSky #BloodSky www.youtube.com/watch?v=0zxm...

📢 Out in the European Journal of Hematology 🙌🏼 Red cell aplasia is uncommon but causes significant morbidity 😭 Daratumumab is effective, well tolerated, and leads to rapid and sustained responses 💪🏼 doi.org/10.1111/ejh....

The #ASH24 community is really ramping up in the last week before sunny San Diego. Looking forward to a phenomenal annual meeting, y'all! #ASHKudos cc @ash-hematology.bsky.social

Let’s have a fresh start! #HematoRules!